Hospira, Inc. FDA Inspection Record

FEI 1021343 · Inspections, Form 483s, warning letters and import refusals

Hospira, Inc. is an FDA-registered facility (FEI 1021343) located in Rocky Mount, NC, US. Registered operations: ANALYSIS; LABEL; MANUFACTURE; PACK. RegDataLab tracks 12 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Feb 7, 2025: No Action Indicated (NAI)
Inspections on record
12 (3 OAI, 5 VAI, 4 NAI)
Last OAI inspection
Nov 15, 2013
Warning letters
1 listed by FDA for this FEI, latest Mar 7, 2014
Form 483 and inspection documents
3 in FDA's reading room
Recalls as the recalling firm
4, latest Jun 15, 2017
Import refusals
2

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 12 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Feb 7, 2025No Action Indicated (NAI)No citations listed
Nov 21, 2019Voluntary Action Indicated (VAI)Investigations of discrepancies, failures (21 CFR 211.192)
Scientifically sound laboratory controls (21 CFR 211.160(b))
Written record of investigation incomplete (21 CFR 211.192)
Feb 2, 2018Voluntary Action Indicated (VAI)Calibration/Inspection/Checking not done (21 CFR 211.68(a))
Procedure Deviations Recorded and Justified (21 CFR 211.100(b))
Test devices not meeting specifications (21 CFR 211.160(b)(4))
Documentation (21 CFR 820.100(b))
May 26, 2016No Action Indicated (NAI)No citations listed
Sep 24, 2015Voluntary Action Indicated (VAI)No citations listed
Jun 13, 2014No Action Indicated (NAI)No citations listed
Nov 15, 2013Official Action Indicated (OAI)No citations listed
Mar 1, 2013Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Training , Education , Experience overall (21 CFR 211.25(a))
Equipment Design, Size and Location (21 CFR 211.63)
Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
and 16 more
Aug 4, 2011Official Action Indicated (OAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Investigations of discrepancies, failures (21 CFR 211.192)
Scientifically sound laboratory controls (21 CFR 211.160(b))
Jun 17, 2011Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Training--operations, GMPs, written procedures (21 CFR 211.25(a))
Buildings of Suitable Size, Construction, Location (21 CFR 211.42(a))
Equipment Design, Size and Location (21 CFR 211.63)
and 13 more

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Jun 15, 2017Class IID-1046-2017Potassium Phosphates Inj., USP, 45 mM (3 mM P/mL) Also contains: 66 mEq K+ (4.4 mEq/mL) 15… and 3 more products
Lack of Sterility Assurance
Jan 10, 2013Class IID-169-2013Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc…
Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial
Oct 6, 2006Class IID-390-7Lidocaine HCl Injection, USP, 1%, 10mg/ml, 30mL single dose vial, NDC 0409-4279-02, Rx…
Product may contain particulates.
Jun 18, 2004Class IID-232-45% Lidocaine HCl and 7.5% Dextrose Injection, USP, 2mL ampul ¿ 5 single ampuls…
Some ampuls were found to contain particulates.

Form 483s and inspection documents

  • 483 on FDA.gov
    FDA listing date Jul 10, 2015, which is not always the inspection or issue date. Published by FDA Jan 18, 2024.
  • 483 on FDA.gov
    Inspection Jul 25, 2011 to Aug 4, 2011 (dates printed on the document). FDA listing date Jul 11, 2015. Published by FDA Jan 18, 2024.
  • 483 on FDA.gov
    Inspection May 16, 2011 to Jun 17, 2011, issued Jun 17, 2011 (dates printed on the document). FDA listing date Jul 11, 2015. Published by FDA Jan 18, 2024.

FDA record score

4 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 22, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

13 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAINov 21, 20196 x 0.251.5
Inspection classified VAIFeb 2, 20186 x 0.251.5
Class II recall D-1046-2017, this FEI as the recalling firmJun 15, 20174 x 0.251
Inspection classified VAISep 24, 201510 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsMar 7, 201410 years or older, so it adds no points0
Inspection classified OAINov 15, 201310 years or older, so it adds no points0
Inspection classified VAIMar 1, 201310 years or older, so it adds no points0
Class II recall D-169-2013, this FEI as the recalling firmJan 10, 201310 years or older, so it adds no points0
Inspection classified OAIAug 4, 201110 years or older, so it adds no points0
Inspection classified VAIJun 17, 201110 years or older, so it adds no points0
Inspection classified OAIJan 19, 201010 years or older, so it adds no points0
Class II recall D-390-7, this FEI as the recalling firmOct 6, 200610 years or older, so it adds no points0
Class II recall D-232-4, this FEI as the recalling firmJun 18, 200410 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 22, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 22, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 22, 2026Newest record Nov 13, 2026Current
Warning letter textNov 22, 2026Newest record Nov 17, 2026Current
Recalls (Enforcement Report)Nov 22, 2026Newest record Nov 18, 2026Current
Form 483s and inspection documentsNov 18, 2026Newest record Nov 17, 2026Current
Import refusalsNov 22, 2026Newest record Nov 12, 2026Current

Reviewing Hospira, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Hospira, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Hospira, Inc.
Location
Rocky Mount, NC (US)
Registration Expires
Dec 31, 2026
Operations
ANALYSIS; LABEL; MANUFACTURE; PACK
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.